Aethlon Medical Shareholder Meeting
Aethlon Medical filed an amendment to its 2026 Annual Meeting results to clarify that Proposal No. 7, which sought to authorize 20 million shares of preferred stock, was not approved by stockholders. Although the proposal received a majority of votes cast, it failed to meet the required threshold of a majority of all outstanding shares. As a result, the company's Articles of Incorporation will not be amended to authorize the new class of preferred stock.